NEW YORK (AP) — Federal authorities said Friday they are investigating claims that Martin Shkreli has been running his pharmaceutical company from behind bars using a contraband smartphone. Shkreli, 35, is serving a seven-year sentence for securities fraud at the Federal Correctional Institution at Fort Dix, New Jersey, a low-security prison complex about 40 miles (65 kilometers) from Philadelphia. Dennis Van Tine/MediaPunch/IPx Former Turing Pharmaceuticals CEO Martin Shkreli, seen in 2017, is suspected of running his pharmaceutical company, Phoenixus AG, from prison. Shkreli also could face disciplinary sanctions within the prison if he is found to have conducted business. “The BOP continually evaluates and deploys as appropriate, contraband-detecting technologies, including walk-through metal detectors and whole-body imaging devices.”Shkreli had been charged with eight counts of securities fraud, conspiracy to commit securities fraud and wire fraud, for his role managing MSMB Capital Management and MSMB Healthcare between 2009 and 2014.

Source: Huffington Post March 10, 2019 17:26 UTC